Yehan Zhang, Shijie Tang, Yi Zhang, Jiahui Liu, Xiaohan Shi, Yikai Li et al. KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. // Cancer Cell. – DOI: 10.1016/j.ccell.2026.10.003. – URL: https://www.sciencedirect.com/science/article/pii/S1535610826004678?dgcid=rss_sd_all
Yehan Zhang, Shijie Tang, Yi Zhang, Jiahui Liu, Xiaohan Shi, Yikai Li, Yunguang Li, Huan Wang, Chaoliang Zhong, Maoyuan Sun, Wenjie Li, Yiqin Zhu, Weiwei Yang, Yun Zhao, Shiwei Guo, Zhongjun Wu, Lin Wang, Gang Jin, & Dong Gao KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.10.003
Yehan Zhang, et al. “KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer.” Cancer Cell. doi:10.1016/j.ccell.2026.10.003.
@article{Zhang,
title = {KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer},
author = {Zhang, Yehan and Tang, Shijie and Zhang, Yi and Liu, Jiahui and Shi, Xiaohan and Li, Yikai and Li, Yunguang and Wang, Huan and Zhong, Chaoliang and Sun, Maoyuan and Li, Wenjie and Zhu, Yiqin and Yang, Weiwei and Zhao, Yun and Guo, Shiwei and Wu, Zhongjun and Wang, Lin and Jin, Gang and Gao, Dong},
journal = {Cancer Cell},
doi = {10.1016/j.ccell.2026.10.003},
url = {https://www.sciencedirect.com/science/article/pii/S1535610826004678?dgcid=rss_sd_all}
}